CB

cbdMD

YCBD
NYSE MKT LLCHealth Care
$0.69
USD
-0.01(-1.73%)
At close: Jun 12, 20:00 UTC

Open

$0.68

Prev. Close

$0.68

High

$0.68

Low

$0.68

Market Snapshot

Market Cap

$7.2M

P/E Ratio

-2.3

EPS

-13.40

Revenue

$19.22M

Employees

42

About

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina. The company went IPO on 2017-11-17. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. The company operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.

Recently from Cashu